Enzymatic DNA synthesis is growing due to demand for faster, sustainable DNA production. Key opportunities: integration, ...

Rocket Lab (RKLB) trades near $102 with a $2.2B backlog and Neutron due Q4 2026. Can RKLB hit the $293 bull case, or slide to ...

VentureBeat Research surveyed 573 enterprise leaders and found AI agent controls lagging deployment, with 86% of GPUs running ...

Optimists once believed that universal literacy was inevitable. Now it seems that the age of reading might be a short anomaly ...

Vertex Pharmaceuticals Incorporated’s $10B Crinetics Pharmaceuticals, Inc. buy adds PALSONIFY & a Phase 3 CAH asset. Click ...

Complex chemical processes are essential for making DNA." This long-held assumption in the field of biotechnology has been overturned by a Korean ...

Many important medicines and agricultural compounds have origins in natural products made by microorganisms. One such ...

Harken back to your early days in organic chemistry class and you’ll recall learning how S N 1 and S N 2 substitution ...

Your website is no longer your digital asset. Your knowledge is. Here's the architectural shift AI is forcing on enterprises.

South Africa’s Fast Food/QSR industry is entering a more strategically competitive phase, where brands are no longer ...

Chief Executive Alex Karp’s recent broadside against the frontier model vendors put a knife to the throat of the central ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of ...